ProQR Therapeutics N.V. (PRQR)

Last Closing Price: 1.10 (2026-11-18)

Earnings per Share (EPS) (Diluted) (Quarterly)

Earnings per Share (EPS) (Diluted): A company's net earnings or losses attributable to common shareholders per diluted share basis, which includes all convertible securities and debt, options and warrants.

ProQR Therapeutics N.V. (PRQR) had Earnings per Share (EPS) (Diluted) of $-0.10 for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$5.93M
$-14.33M
--
$5.93M
$21.05M
$-15.12M
$0.79M
$-14.33M
$-14.33M
$-14.33M
$-14.33M
$-14.33M
$-14.33M
$-15.12M
$-14.24M
141.23M
141.23M
$-0.10
Earnings per Share (EPS) (Diluted)
$-0.10
Balance Sheet Financials
$124.37M
$12.71M
$12.71M
$137.08M
$38.79M
--
$19.81M
$58.60M
$78.48M
$78.48M
$78.48M
143.47M
Cash Flow Statement Financials
$-42.59M
$-0.93M
$55.17M
$106.37M
$118.54M
$12.17M
$4.55M
--
--
Fundamental Metrics & Ratios
3.21
--
--
--
0.07
100.00%
-254.80%
-254.80%
--
-241.45%
-241.45%
$-43.52M
--
--
--
0.04
--
1.20
74.81
-18.25%
-18.25%
-10.45%
-18.25%
$0.55
$-0.31
$-0.30